Stability-indicating RP-HPLC method development and validation for duloxetine hydrochloride in tablets

Journal of AOAC International

Volumn 93, Issue 1, 2010, Pages 123-132

  Patel, Sejal K ^a   Patel, Natavarlal J ^a   Prajapati, Arun M ^a   Patel, Dipti B ^a   Patel, Satish A ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DEGRADATION; PARTICLE SIZE; PARTICLE SIZE ANALYSIS;

AMMONIUM ACETATE; CONCENTRATION RANGES; DEGRADATION PRODUCTS; DRUG SUBSTANCES; DULOXETINE HYDROCHLORIDE; PHOTODIODE ARRAY DETECTIONS; STABILITY-INDICATING; STRESS CONDITION;

DRUG PRODUCTS;

EID: 77950005768     PISSN: 10603271     EISSN: None     Source Type: Journal    
DOI: 10.1093/jaoac/93.1.123     Document Type: Article

References (20)

1. O'Neil, M.J. (2006) The Merck Index, 14th Ed, Merck & Co., Inc., Whitehouse Station, NJ, p. 3465
2. Mishra, L. (2006) Drug Today, Vol.1, Lorina Publications Inc., Delhi, India, p. 489
3. Chalon, S.A., Granier, L.-A., Vandenhende, F.R., Bieck, P.R., Bymaster, F.P., Joliat, M.J., Hirth, C., & Potter, W.Z. (2003) J. Neuropsychopharmacol. 28, 1685-1693
4. Turcotte, J.E., Delonnel, G., de Montgny, C., Hébert, C., & Blier, P. (2001) J. Neuropsychopharmacol. 24, 511-521
5. Lantz, R.J., Gillespie, T.A., Rash, T.J., Kuo, F., Skinner, M., Kuan, H.-Y., & Knadler, M.P. (2003) Drug Metab. Disp. 31, 1142-1150
6. Michel, M.C., & Oelke, M. (2005) Future Med. 1, 345-358
7. Bauer, M., Möller, J.M., & Edith, S. (2006) Expert Opin. Pharmacothera. 7, 421-427
8. Johnson, J.T., Oldham, S.W., Lantz, R.J., & DeLong, A.F. (1996) J. Liq. Chromatogr. Relat. Tech. 19, 1631-1641
9. Pankaj, S., Mariappan, T.T., & Banerjee, U.C. (2005) Talanta 67, 975-978
10. Brenna, E., Frigoli, S., Fonza, G., Fuganti, C., & Malpezzi, L. (2007) J. Pharm. Biomed. Anal. 43, 1573-1575
11. Jansen, P.J., Oren, P.L., Kemp, C.A., Maple, S.R., & Baertschi, S.W. (1998) J. Pharm. Sci. 87, 81-85
12. Kamila, M.M., Mondai, N., & Ghosh, L.K. (2007) Pharmazie 62, 414-415
13. Olsen, B.A., & Argentine, M.D. (1996) J. Liq. Chromatogr. Relat. Technol. 19, 1993-2007
14. International Conference on Harmonization (1996) Topic Ql C Stability Testing for New Dosage Forms, ICH, Geneva, Switzerland
15. International Conference on Harmonization ( 1994) Q2A Validation of Analytical Procedure: Methodology, ICH, Geneva, Switzerland
16. International Conference on Harmonization (1996) Q2B Validation of Analytical Procedure: Methodology, ICH, Geneva, Switzerland
17. International Conference on Harmonization (2002) Guideline on Analytical Method Validation, International Convention on Quality for the Pharmaceutical Industry, ICH, Toronto, Canada
18. U.S. Food and Drug Administration (1994) Reviewer Guidance, Validation of Chromatographic Methods, Center for Drug Evaluation and Research, Rockville, MD
19. Moffat, A.C., Osselten, M.D., & Widdop, B. (2004) Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material, 3rd Ed, Pharmaceutical Press, London, UK, p. 1370
20. International Conference on Harmonization (1996) Topic Q1B, Photo Stability Testing of New Drug Substances and Products, ICH, Geneva, Switzerland